| GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL |
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care. |
zacks.com |
2025-05-16 15:16:07 |
Czytaj oryginał (ang.) |
| GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use |
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging. |
zacks.com |
2025-05-15 15:55:19 |
Czytaj oryginał (ang.) |
| GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and changes in the distribution of contrast during CBCT acquisitions in liver, prostate, neuro, and endovascular aortic repair pro. |
businesswire.com |
2025-05-15 12:00:00 |
Czytaj oryginał (ang.) |
| GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech |
GE HealthCare unveils SIGNA Sprint MRI, a high-performance 1.5T system designed to boost diagnostic accuracy, accelerate imaging, and advance cardiac and cancer care. |
zacks.com |
2025-05-13 14:31:25 |
Czytaj oryginał (ang.) |
| GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent |
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible heart a. |
businesswire.com |
2025-05-13 13:00:00 |
Czytaj oryginał (ang.) |
| GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology |
CHICAGO & SAN RAMON, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of enhancing the detection of fetal distress during childbirth. Incorporating ox. |
businesswire.com |
2025-05-13 12:00:00 |
Czytaj oryginał (ang.) |
| Here's Why GE HealthCare Stock Blasted Higher Today |
A thawing in the U.S./China trading relationship is excellent news for a company like GE HealthCare Technologies (GEHC 6.08%). It's a large exporter to China (a market management sees as having excellent long-term potential) and uses Chinese-sourced components in its products. |
fool.com |
2025-05-12 18:12:34 |
Czytaj oryginał (ang.) |
| GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system |
HONOLULU--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas. The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular di. |
businesswire.com |
2025-05-12 12:00:00 |
Czytaj oryginał (ang.) |
| MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know |
Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure. |
zacks.com |
2025-05-05 20:00:40 |
Czytaj oryginał (ang.) |
| Here's Why GE HealthCare Stock Sank in April |
Shares in medical equipment company GE HealthCare Technologies (GEHC 4.29%) declined by 12.9% in April, according to data provided by S&P Global Market Intelligence. The key reason for the decline comes from the "Liberation Day" tariffs announced by President Donald Trump at the start of the month. |
fool.com |
2025-05-05 12:35:19 |
Czytaj oryginał (ang.) |
| ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen. |
businesswire.com |
2025-05-02 13:00:00 |
Czytaj oryginał (ang.) |
| GE HealthCare's Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025 |
On Wednesday, GE HealthCare GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago. |
benzinga.com |
2025-05-01 18:25:22 |
Czytaj oryginał (ang.) |
| GE Healthcare sees tariffs costing $500 million in 2025, then much less next year |
GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%. |
marketwatch.com |
2025-04-30 18:39:00 |
Czytaj oryginał (ang.) |
| GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises |
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing. |
zacks.com |
2025-04-30 16:25:30 |
Czytaj oryginał (ang.) |
| GE HealthCare Blames Tariffs For Lowering 2025 Profit Outlook, Initiates Stock Buyback |
On Wednesday, GE HealthCare GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago. |
benzinga.com |
2025-04-30 15:28:45 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript |
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joanne Wuensch - Citi Craig Bijou - BofA Securities Anthony Petrone - Mizuho Financial Group Operator Good day, and thank you for standing by. Welcome to the GE HealthCare First Quarter 2025 Earnings Conference Call. |
seekingalpha.com |
2025-04-30 15:22:15 |
Czytaj oryginał (ang.) |
| Tariffs Weigh on GE HealthCare Outlook |
Here's our initial take on GE HealthCare's (GEHC 3.14%) first-quarter financial report. |
fool.com |
2025-04-30 15:07:00 |
Czytaj oryginał (ang.) |
| GE HealthCare beats on earnings, slashes full year outlook due to tariffs |
GE HealthCare reported better-than-expected first-quarter results, beating analysts' estimates on top and bottom lines. The company slashed its annual forecast to account for the impact of President Donald Trump's tariff policy. |
cnbc.com |
2025-04-30 14:43:07 |
Czytaj oryginał (ang.) |
| GE HealthCare (GEHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates |
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-04-30 14:36:12 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies (GEHC) Q1 Earnings and Revenues Top Estimates |
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.90 per share a year ago. |
zacks.com |
2025-04-30 12:30:38 |
Czytaj oryginał (ang.) |
| GE HealthCare names new president and CEO, China |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare's new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao's departure. Yihao's planned retirement allowed GE Heal. |
businesswire.com |
2025-02-27 04:00:00 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy? |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-02-24 12:45:42 |
Czytaj oryginał (ang.) |
| Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging |
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek, announces a collaboration with GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. |
globenewswire.com |
2025-02-17 12:25:00 |
Czytaj oryginał (ang.) |
| Why Is GE HealthCare Stock Trading Soaring On Thursday? |
On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26. |
benzinga.com |
2025-02-13 15:25:17 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript |
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO Jay Saccaro - VP and CFO Conference Call Participants Anthony Petrone - Mizuho Financial Group Craig Bijou - BofA Securities Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Robbie Marcus - JPMorgan Operator Good day, and thank you for standing by. Welcome to the GE HealthCare Fourth Quarter and Full Year 2024 Earnings Conference Call. |
seekingalpha.com |
2025-02-13 14:21:13 |
Czytaj oryginał (ang.) |
| GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises |
GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing. |
zacks.com |
2025-02-13 11:25:21 |
Czytaj oryginał (ang.) |
| GE HealthCare Tops Q4 EPS Forecasts |
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (GEHC -1.30%) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27. |
fool.com |
2025-02-13 10:39:07 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates |
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago. |
zacks.com |
2025-02-13 10:32:16 |
Czytaj oryginał (ang.) |
| GE HealthCare forecasts upbeat 2025 profit on steady medical device demand |
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China. |
reuters.com |
2025-02-13 09:37:38 |
Czytaj oryginał (ang.) |
| GE HealthCare Posts Q4 Profit Above Expectations |
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates. |
investopedia.com |
2025-02-13 09:10:46 |
Czytaj oryginał (ang.) |
| GE Healthcare's business grows with boost from imaging and diagnostic drug units |
The company said it was “pleased with |
marketwatch.com |
2025-02-13 09:03:00 |
Czytaj oryginał (ang.) |
| GE HealthCare Stock Rises on Strong Earnings and Outlook |
The medical imaging company issues solid guidance for 2025. |
barrons.com |
2025-02-13 09:02:00 |
Czytaj oryginał (ang.) |
| GE HealthCare reports fourth quarter and full year 2024 financial results |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President and CEO Peter Arduini said, “We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our Advanced Visualization Solutions and Pharmaceutical Diagnostics businesses, with overall strength in the U.S., and r. |
businesswire.com |
2025-02-13 08:20:00 |
Czytaj oryginał (ang.) |
| GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness? |
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver. |
zacks.com |
2025-02-10 16:46:09 |
Czytaj oryginał (ang.) |
| PAHC vs. GEHC: Which Stock Is the Better Value Option? |
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors? |
zacks.com |
2025-02-10 14:46:33 |
Czytaj oryginał (ang.) |
| What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings |
Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. |
zacks.com |
2025-02-10 12:20:21 |
Czytaj oryginał (ang.) |
| GEHC Stock May Rise With $138M Investment in Cork Facility Expansion |
GE HealthCare invests $138M to expand its Cork facility to enhance manufacturing capacity for life-saving imaging contrast media and strengthen its global supply chain. |
zacks.com |
2025-02-04 10:36:11 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series |
GE HealthCare launches the enhanced Voluson Expert Series to advance women's health with faster, more precise imaging for improved care in obstetrics and gynecology. |
zacks.com |
2025-02-03 14:41:39 |
Czytaj oryginał (ang.) |
| GE HealthCare Technologies: Still A Solid Long-Term Play |
GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth, outperforming the S&P 500 by a wide margin. Despite mixed financial performance, the company remains undervalued compared to competitors, with potential for further growth in a large, expanding market. Management's optimistic guidance for 2024 and beyond, coupled with strategic investments and partnerships, supports continued revenue and profit growth. |
seekingalpha.com |
2025-02-03 06:58:52 |
Czytaj oryginał (ang.) |
| GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand |
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand. |
businesswire.com |
2025-01-31 05:00:00 |
Czytaj oryginał (ang.) |
| United States External Cardiology Remote Monitors Market Outlook to 2033 Featuring Key Players, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics, and Nihon Kohden |
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "United States External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - External Cardiology Remote Monitors |
globenewswire.com |
2025-01-02 11:04:00 |
Czytaj oryginał (ang.) |
| GEHC vs. PODD: Which Stock Is the Better Value Option? |
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-12-31 14:41:11 |
Czytaj oryginał (ang.) |
| 5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More |
Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care. |
zacks.com |
2024-12-30 10:31:10 |
Czytaj oryginał (ang.) |
| Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-12-25 12:46:18 |
Czytaj oryginał (ang.) |
| 2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens |
GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook for 2025 is supported by GEHC's AI advancements, expected sales and profitability improvements, and a significant backlog of $19.6 billion. AI-driven healthcare solutions are projected to enhance diagnostic accuracy, reduce treatment costs, and drive market growth, with GEHC positioned as a leader with numerous FDA-approved devices. |
seekingalpha.com |
2024-12-19 10:06:27 |
Czytaj oryginał (ang.) |
| Reasons to Retain GE HealthCare Stock in Your Portfolio Now |
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock. |
zacks.com |
2024-12-18 10:41:14 |
Czytaj oryginał (ang.) |
| GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher |
GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovations, including the FDA-approved Flyrcado, and potential recovery in Chinese demand. Margins are expected to improve through cost optimization, volume leverage, and strategic pricing, with a medium-term EBIT margin target of high teens to 20%. |
seekingalpha.com |
2024-12-06 19:25:25 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain Following the Launches of Aurora and Clarify DL |
GE HealthCare announces that Aurora will expand the range of CT procedures and Clarify DL will enhance SPECT image quality. |
zacks.com |
2024-12-05 14:46:11 |
Czytaj oryginał (ang.) |
| GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Radiological Society of North America (RSNA) 2024 Annual Meeting, in Chicago, IL. Understanding the need to improve operational efficiencies within radiology departments and the ongoing challenge of burnout experienced by clinicians, GE HealthCare developed the technologies to deliver exceptional imag. |
businesswire.com |
2024-12-05 11:00:00 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL |
GE HealthCare announces the FDA submission of its CleaRecon DL technology to improve CBCT images. |
zacks.com |
2024-12-04 15:30:28 |
Czytaj oryginał (ang.) |
| GE HealthCare showcases commitment to sustainable innovation at RSNA 2024 |
CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions with increased focus on sustainability at the Radiological Society of North America (RSNA) 2024 Annual Meeting, which is held Dec. 1-4 in Chicago, IL. “With a deep appreciation for the importance of sustainability, at GE HealthCare, we are managing our environmental footprint by integrating sustain. |
businesswire.com |
2024-12-04 11:00:00 |
Czytaj oryginał (ang.) |
| Trade Tracker: Stephanie Link sells Lam Research, GE Healthcare and buys more Gap, CrowdStrike |
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to reveal her latest portfolio moves. |
youtube.com |
2024-12-03 15:42:26 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging |
GE HealthCare announces the new Sonic DL for 3D, which will reduce scan times and provide faster, high-quality imaging for the majority of MR scans. |
zacks.com |
2024-12-02 14:25:41 |
Czytaj oryginał (ang.) |
| GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical |
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical. |
businesswire.com |
2024-12-02 01:45:00 |
Czytaj oryginał (ang.) |
| GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI |
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging portfolio, designed to accelerate MRI scans across a wide range of clinical applications. Sonic DL for 3D builds on GE HealthCare's deep learning innovation legacy and the success of AIR Recon DL, which has helped over 34 million patients to date. Initially launched in 2023 for Cardiac MRI, Sonic DL provides up to 12 times scan acceleration while maintaining dia. |
businesswire.com |
2024-12-01 14:30:00 |
Czytaj oryginał (ang.) |
| GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024 |
CHICAGO--(BUSINESS WIRE)--At the Radiological Society of North America's (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more than 40 innovations, including several key artificial intelligence (AI)-enabled technologies to optimize patient care and increase operational efficiencies. GE HealthCare products are designed to increase efficiency and help seamlessly integrate data to support precision care across multiple care pathways. These. |
businesswire.com |
2024-12-01 11:00:00 |
Czytaj oryginał (ang.) |
| GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care |
The latest collaboration aims to provide new opportunities to improve cancer diagnosis using GE HealthCare's technology and enhance clinical workflow. |
zacks.com |
2024-11-29 13:25:19 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain Following the Launch of Pristina Via System |
GE HealthCare announces the Pristina Via mammography system, which will help minimize repetitive tasks and streamline workflows for mammography technologists. |
zacks.com |
2024-11-27 13:01:08 |
Czytaj oryginał (ang.) |
| GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care |
CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America's 2024 Annual Meeting, this innovation provides mammography technologists with a suite of sophisticated tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centered breast care. Recent data from the American Soc. |
businesswire.com |
2024-11-26 11:00:00 |
Czytaj oryginał (ang.) |
| GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio |
GE HealthCare announces the latest application additions to its OEC 3D mobile CBCT C-arm portfolio to improve clinician workflow and visualization during endoscopic bronchoscopy procedures. |
zacks.com |
2024-11-25 12:45:30 |
Czytaj oryginał (ang.) |